DABIGATRAN
Active substance: dabigatran etexilate
CAPSULE · DABIGATRAN ETEXILATE MESYLATE 150 mg/1
United StatesActive
Marketing holder: AvPAK
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- DABIGATRAN ETEXILATE MESYLATE · 150 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 4 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2d64-7d1c-98a9-93016b4378d5,01a1208c-32a6-7dce-b827-f878ec065dcf,01a1208c-32a9-71f9-a326-ccffd4b9482b,01a1208c-449e-7020-b866-85c48467118b,01a1208c-5e11-76b7-936b-dc6116ba9016;count=50 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50268-200
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 50268-200 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50268-200 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50268-200 · Verified 2026-10-09 · open in source